Is This the Next Home-Run Biotech Stock? [The Motley Fool]
Axon Enterprise, Inc. (AXON)
Last axon enterprise, inc. earnings: 2/7 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.axovant.com/investors/sec-filings
Company Research
Source: The Motley Fool
Axovant Sciences has big data coming this year in Alzheimer's disease that could cause shares to skyrocket. Alzheimer's disease is incredibly tough to treat, and 99% of Alzheimer's disease drugs to enter clinical trials have failed. But Axovant Sciences ( NYSE:AXON ) thinks it's designed a trial that can pan out, and given that its management includes been-there and done-that leaders, it may not be smart to bet against it. Two is better than one Axovant Sciences' lead drug candidate is RVT-101, or intepirdine, a 5HT6 receptor antagonist the company bought out of GlaxoSmithKline 's discard bin in 2014 for $5 million upfront, plus another $5 million last year. IMAGE SOURCE: GETTY IMAGES. Intepirdine stimulates the production of acetycholine, a neurotransmitter that sends signals between nerve cells. Because acetycholine is important to cognitive function, Axovant Sciences thinks using intepirdine alongside the top-selling Alzheimer's disease drug Aricept, whi
Show less
Read more
Impact Snapshot
Event Time:
AXON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXON alerts
High impacting Axon Enterprise, Inc. news events
Weekly update
A roundup of the hottest topics
AXON
News
- Will Axon (AXON) Beat Estimates Again in Its Next Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Here's Why Axon Enterprise (AXON) is a Strong Growth Stock [Yahoo! Finance]Yahoo! Finance
- Axon Enterprise (AXON) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]Yahoo! Finance
- Axon Enterprise Insiders Placed Bullish Bets Worth US$8.74m [Yahoo! Finance]Yahoo! Finance
- Earnings Growth & Price Strength Make Axon Enterprise (AXON) a Stock to Watch [Yahoo! Finance]Yahoo! Finance
AXON
Earnings
- 2/27/24 - Beat
AXON
Sec Filings
- 4/19/24 - Form POSASR
- 4/15/24 - Form DEFA14A
- 4/15/24 - Form DEFA14A
- AXON's page on the SEC website